Director, Global Program Lead, External Innovation & Due Diligence

Role: Serve as R&D project lead for external opportunity due diligence, focusing on clinical-stage assets in neuroscience, psychiatry, neuro-rare, and rare diseases. Responsibilities: lead cross-functional evaluation of external assets, develop diligence workplans, create integrated development scenarios, and synthesize scientific, clinical, regulatory, and financial data into strategic recommendations for senior leadership. Collaborate with Business Development and internal teams to support in-licensing, acquisition, and partnership evaluations; contribute to portfolio prioritization and external network engagement. Requirements: Bachelor's degree in a relevant scientific discipline; 10-12 years in pharma/biotech R&D, with experience in clinical-stage program management, portfolio strategy, and cross-functional asset evaluation; strong scientific evaluation skills, especially in neuroscience or rare diseases preferred; proven ability to synthesize complex data and influence in a matrix environment. HighValue: focus on neuroscience, psychiatry, neuro-rare, and rare disease therapeutics; clinical-stage assets; strategic evaluations supporting licensing and partnership decisions; global collaboration. WorkSetup: hybrid model in San Diego, San Francisco, or Princeton with an average of three days in-office; some domestic and international travel required.